An expert panel has advised the Food and Drug Administration not to approve a new drug for attention deficit hyperactivity disorder. Panel members say the drug isn't safe enough to give to millions of ...

When child psychiatrists gather, presentations on ADHD almost always orbit around the use of stimulants—methylphenidate and amphetamine in their many formulations. At this year’s Texas Society of ...